Open-Label Placebo for Functional Dyspepsia
Public ClinicalTrials.gov record NCT03745781. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The study is evaluating the efficacy of open-label placebo for the treatment of functional dyspepsia.
Study identification
- NCT ID
- NCT03745781
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Early Phase 1
- Enrollment
- 21 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2018
- Primary completion
- Oct 6, 2019
- Completion
- Oct 6, 2019
- Last update posted
- May 5, 2020
2018 – 2019
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Beth Israel Deaconess Medical Center | Boston | Massachusetts | 02215 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Dyspepsia trials
Other public records listing Dyspepsia. Sorted by last update posted; newest first. Not a recommendation.
- NCT07717541: Virtual Poetry Workshops to Enhance Patient Well Being and Reduce Anxiety Recruiting
- NCT06241183: Famotidine and Antacids for Treatment of Dyspepsia Recruiting
- NCT01696734: Domperidone in Treating Patients With Gastrointestinal Disorders Recruiting
- NCT06369753: Visible Abdominal Distension Recruiting
- NCT03603730: Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis Recruiting
- NCT05587127: Exposure-Based CBT for Avoidant/Restrictive Food Intake in Functional Dyspepsia Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03745781, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 5, 2020 · Synced Sep 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03745781 live on ClinicalTrials.gov.